[go: up one dir, main page]

BR9714641A - Mutantes de toxina a de estreptococo e métodos de uso - Google Patents

Mutantes de toxina a de estreptococo e métodos de uso

Info

Publication number
BR9714641A
BR9714641A BR9714641-2A BR9714641A BR9714641A BR 9714641 A BR9714641 A BR 9714641A BR 9714641 A BR9714641 A BR 9714641A BR 9714641 A BR9714641 A BR 9714641A
Authority
BR
Brazil
Prior art keywords
toxin
methods
spe
mutants
vaccine
Prior art date
Application number
BR9714641-2A
Other languages
English (en)
Inventor
Patrick M Schlievert
Manuela Roggiani
Jennifer Stoehr
Douglas Ohlendorf
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of BR9714641A publication Critical patent/BR9714641A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"MUTANTES DE TOXINA A DE ESTREPTOCOCO E MéTODOS DE USO". A presente invenção refere-se a toxina SPE-A mutantes ou seus fragmentos, vacina e composições farmacêuticas e métodos de uso da vacina e das composições farmacêuticas. A toxina SPE-A preferida tem pelo menos uma mudança de aminoácido e é substancialmente não letal em comparação com a toxina SPE-A do tipo selvagem. As toxinas SPE-A mutantes podem formar composições de vacina úteis para proteger animais das atividades biológicas da toxina SPE-A do tipo selvagem.
BR9714641-2A 1996-12-06 1997-12-05 Mutantes de toxina a de estreptococo e métodos de uso BR9714641A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3293096P 1996-12-06 1996-12-06
PCT/US1997/022228 WO1998024911A2 (en) 1996-12-06 1997-12-05 Mutants of streptococcal toxin a and methods of use

Publications (1)

Publication Number Publication Date
BR9714641A true BR9714641A (pt) 2002-01-22

Family

ID=21867628

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714641-2A BR9714641A (pt) 1996-12-06 1997-12-05 Mutantes de toxina a de estreptococo e métodos de uso

Country Status (11)

Country Link
US (2) US6913755B2 (pt)
EP (1) EP0948624B1 (pt)
JP (1) JP2001505439A (pt)
KR (1) KR100548663B1 (pt)
CN (1) CN1211487C (pt)
AT (1) ATE346860T1 (pt)
AU (1) AU7625798A (pt)
BR (1) BR9714641A (pt)
CA (1) CA2273822A1 (pt)
DE (1) DE69737032D1 (pt)
WO (1) WO1998024911A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW517061B (en) * 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use
ATE346860T1 (de) * 1996-12-06 2006-12-15 Univ Minnesota Mutanten von streptococcaltoxinen und vefahren zu deren anwendung
US7087235B2 (en) * 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
US6872394B1 (en) 1997-12-02 2005-03-29 Idaho Research Foundation, Inc. Non-toxic immune stimulating enterotoxin compositions
WO2002083169A1 (en) * 2001-04-13 2002-10-24 Idaho Research Foundation, Inc. Modified staphylococcal enterotoxins and expression systems therefore
SE0102327D0 (sv) * 2001-06-28 2001-06-28 Active Biotech Ab A novel engineered superantigen for human therapy
ATE512978T1 (de) * 2001-11-26 2011-07-15 U S Medical Res Inst Of Infectious Diseases Bakterielle superantigenimpfstoffe
US8299249B2 (en) * 2007-03-01 2012-10-30 Basf Se Method for producing TETA by means of EDDN
JP7161938B2 (ja) 2016-01-10 2022-10-27 ネオティーエックス セラピューティクス リミテッド スーパー抗原媒介性癌免疫療法の能力を増強するための方法および組成物
MX2020012245A (es) * 2018-05-16 2021-01-29 Univ Griffith Sindrome de choque toxico estreptococico.
EP3969043A1 (en) 2019-05-15 2022-03-23 Neotx Therapeutics Ltd. Cancer treatment
KR20220150353A (ko) 2020-03-05 2022-11-10 네오티엑스 테라퓨틱스 엘티디. 면역 세포를 사용하여 암을 치료하기 위한 방법 및 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172126A (en) * 1976-11-08 1979-10-23 Sankyo Company Limited Method for the inactivation of microbial toxins and attenuation of vaccines
US4784948A (en) 1983-08-10 1988-11-15 The Rockefeller University Production of streptococcal m protein immunogens and molecular probes
US5298396A (en) 1989-11-15 1994-03-29 National Jewish Center For Immunology And Respiratory Medicine Method for identifying T cells disease involved in autoimmune disease
US5336598A (en) 1989-11-15 1994-08-09 National Jewish Center For Immunology And Respiratory Medicine Method for diagnosing a superantigen caused pathologial condition via assay of T-cells
CA2128415A1 (en) 1992-01-28 1993-08-05 John W. Kappler Protective effects of mutated superantigens
KR100456594B1 (ko) 1995-06-07 2005-06-17 리전츠 오브 더 유니버스티 오브 미네소타 스트렙토코커스독소a의변이체및그의사용방법
ATE346860T1 (de) * 1996-12-06 2006-12-15 Univ Minnesota Mutanten von streptococcaltoxinen und vefahren zu deren anwendung

Also Published As

Publication number Publication date
CN1246151A (zh) 2000-03-01
KR100548663B1 (ko) 2006-02-03
CA2273822A1 (en) 1998-06-11
KR20000069316A (ko) 2000-11-25
EP0948624B1 (en) 2006-11-29
AU7625798A (en) 1998-06-29
JP2001505439A (ja) 2001-04-24
WO1998024911A3 (en) 1998-08-20
DE69737032D1 (de) 2007-01-11
US20060041107A1 (en) 2006-02-23
EP0948624A2 (en) 1999-10-13
ATE346860T1 (de) 2006-12-15
US20020086813A1 (en) 2002-07-04
CN1211487C (zh) 2005-07-20
WO1998024911A2 (en) 1998-06-11
US6913755B2 (en) 2005-07-05

Similar Documents

Publication Publication Date Title
BR9714641A (pt) Mutantes de toxina a de estreptococo e métodos de uso
PT832241E (pt) Mutantes de toxina a estreptococica e metodos de utilizacao
BR9713679A (pt) Mutantes de toxina c de estreptococo e métodos de uso
BR9812079A (pt) Salmonella sp. mutante, lipopolissacarìdeo, processo para inibir o crescimento ou reduzir o volume de um câncer de tumor sólido, composição farmacêutica, e, processo aperfeiçoado para selecionar alterações genéticas em uma bactéria.
DE69534992D1 (de) Mutierendes enterotoxin als nichttoxisches orales adjuvans
ES2096262T3 (es) Nuevas cyclosporins modificadas en la posicion 1.
HUP9801240A2 (en) Oral compositions
TR200901109T1 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
BR9610872A (pt) Proteìna receptora de transferrina de moraxella
DK0816378T3 (da) Antibiotiske glycopeptidamidderivater
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
IE860089L (en) Spergualin compositions
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ATE287963T1 (de) Pseudomonas exotoxin - myelin basisches protein chimäre proteine
BR0014740A (pt) Lantibiótico
NZ503463A (en) Leukotoxin deletion mutant of Pasteurella haemolytica
ATE173608T1 (de) Präparat gegen haarausfall und brüchiche nägel
DE69737476D1 (de) Neuer galaninrezeptor
ATE103979T1 (de) Menschliches lymphotoxin.
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
FR2707492B1 (fr) Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
SE9604439D0 (sv) New receptor
BR0007255A (pt) Derivados carbamato de diaril 1,3,4-oxadiazolona
EP0722714A3 (en) Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them
BR9809405A (pt) Proteinase de streptococcus pneumoniae que degrada complemento humano c3

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO, DE ACORDO COM ARTIGO 8O DA LPI